about
Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B in a piglet model.Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in miceVaccines are for dinner.Protection against pneumonic plague following oral immunization with a non-replicating vaccine.Bacillus subtilis: a temperature resistant and needle free delivery system of immunogens.Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.Needle-free vaccine delivery.Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria.Age-related decline in immunity: implications for vaccine responsiveness.Oral vaccine delivery: can it protect against non-mucosal pathogens?Delivery systems: a vaccine strategy for overcoming mucosal tolerance?Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs.Transgenic plant-based oral vaccines.Topical immunization strategies.Bioadhesive delivery systems for mucosal vaccine delivery.Controlled delivery systems: from pharmaceuticals to cells and genes.Trends in vaccine adjuvants.Feasibility of Pisum sativum as an expression system for pharmaceuticals.New approaches in oral rotavirus vaccines.Current state and challenges in developing oral vaccines.Surface display of N-terminally anchored invasin by Lactobacillus plantarum activates NF-κB in monocytes.Live-vaccinia virus encapsulation in pH-sensitive polymer increases safety of a reservoir-targeted Lyme disease vaccine by targeting gastrointestinal release.A phase trial of the oral Lactobacillus casei vaccine polarizes Th2 cell immunity against transmissible gastroenteritis coronavirus infection.Chitosan microparticles loaded with yeast-derived PCV2 virus-like particles elicit antigen-specific cellular immune response in mice after oral administration.Thermoresponsive Bacteriophage Nanocarrier as a Gene Delivery Vector Targeted to the Gastrointestinal Tract.Proof of concept in utilizing in-trans surface display system of Lactobacillus plantarum as mucosal tuberculosis vaccine via oral administration in miceParticulate transepithelial drug carriers: barriers and functional polymers
P2860
Q34044951-AA7FB19B-E7A8-47C4-BABD-325C8A6F5FE6Q34580095-64482F82-3D2B-4A07-8FF9-281D296336DDQ35865035-8C79A837-D450-4847-84F1-98CEBE4F7C52Q36099515-A8C60C30-4701-49DD-A807-E12195FEC0B8Q36391905-B700EFE1-B1DD-4DFD-826F-710939EC516CQ36804213-D35E8116-4C84-4B7D-A658-97ECF8112D1CQ36945838-6C5F2824-14FC-47CB-9786-86C37B63DD2DQ37111626-4799CB7B-210C-4196-92A0-79B8991AD66CQ37150322-438B65DD-7CE1-4C13-BB87-B7CE99AD4FEEQ37229915-83AA8BEA-D209-4C00-A04F-26FE7DC6A2D9Q37354182-31B62245-5CFE-41A2-B4EF-C3EA105C187AQ37537840-3A03EF89-7AE8-4796-9DFA-676AB6DC6E53Q37744913-1C2CE449-1FB9-4421-830F-3DD54EB9E1DBQ37791415-A81B1833-C531-4708-ADE2-2E20518E66A1Q37805519-2C9F43BC-BDC7-4F50-AE8D-23F741ECFB06Q37855597-64963CE0-EDB1-4895-AB47-17C5006909FEQ37867107-A797E149-AD4B-4E1C-BEB2-999971687FC3Q37953235-9AD3C099-59B9-4033-9D60-AC893B589C30Q38255552-09E9CF4F-543B-46EB-A6DD-090E503BDF26Q39259629-22064A90-F7D3-4037-9137-522645140EBDQ39329973-7052BAEC-A4DB-4797-B88C-B824C0640919Q40583822-51DECE99-00CF-4580-8E61-DA2A4B3F9E4CQ40738737-480877F2-661B-408D-AD2B-B52B1A4208A8Q42198915-E4FF016A-EA67-4F70-8841-D307756CCF1EQ55514759-5A76DA02-73E8-409B-8A58-056294DF79E6Q57474585-C9CE2378-995F-4B0D-BDD6-B62B98C8B934Q58385253-28013967-A4DD-4943-8F95-F337F3E149DF
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Delivery systems and adjuvants for oral vaccines.
@ast
Delivery systems and adjuvants for oral vaccines.
@en
type
label
Delivery systems and adjuvants for oral vaccines.
@ast
Delivery systems and adjuvants for oral vaccines.
@en
prefLabel
Delivery systems and adjuvants for oral vaccines.
@ast
Delivery systems and adjuvants for oral vaccines.
@en
P2860
P356
P1476
Delivery systems and adjuvants for oral vaccines
@en
P2093
D T O'Hagan
P2860
P304
P356
10.1517/17425247.3.6.747
P407
P577
2006-11-01T00:00:00Z